Evidence map›Paper›PMID 39538976›Full record

ReviewChemistryOpen2025

Recent Advances in the Synthesis of Commercially Available Phosphite Antioxidants.

Yuliang Zhu, Xinyue Liu, Ying Tang, Kexin Xu, Xin Tang, Longzhi Zhu, Biquan Xiong

Abstract readReview
In one paragraph

Review in ChemistryOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuliang ZhuDepartment of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.
Xinyue LiuSchool of Economics and Management, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.
Ying TangDepartment of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.
Kexin XuSchool of Economics and Management, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.
Xin TangDepartment of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.
Longzhi ZhuDepartment of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.ORCID https://orcid.org/0000-0001-5161-9944
Biquan XiongDepartment of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, P. R. China.

Funding

Natural Science Foundation of Hunan Province 2023JJ30274Scientific Research Fund of Hunan Provincial Education Department 23A0497Scientific Research Fund of Hunan Provincial Education Department 23B0634
6 · The paper itself

Abstract

Phosphite antioxidants exhibit superior anti-aging and color-stabilizing properties when incorporated into polymer materials. Their synergistic antioxidative effects are particularly noteworthy when used in combination with hindered phenol antioxidants and other primary antioxidants, serving as effective secondary antioxidants, displaying noteworthy synergistic antioxidation effects. This review systematically classifies the synthetic methods for phosphite antioxidants into three distinct categories based on the types of starting materials: synthesis from phosphorus trichloride, phosphorus-containing esters, and white phosphorus. Additionally, it delineates the reaction mechanisms associated with these approaches and provides an overview of future potential research directions and applications for organophosphorus antioxidants.

Indexed as

AntioxidantsIndustrial productsNucleophilic substitutionPhosphitesSynthesis

Identifiers

PMID39538976
PMCPMC12128154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.